Sort
39,280 grants matching “leukemia”
3H-pyrazolo[4,3-f]quinoline-containing compounds as selective and tunable protein kinase inhibitors
$434,910Herman O Sintim · Purdue University · R01 · FY2024 · CA
Molecular Genetics
$434,909Carlo M Croce · University Of California, San Diego · P01 · FY2016 · CA
Corepressor regulation of nuclear receptor action
$434,791Anthony N Hollenberg · Beth Israel Deaconess Medical Center · R01 · FY2010 · DK
Regulation and Targets of the DNA Damage Checkpoint
$434,766David P Toczyski · University Of California, San Francisco · R01 · FY2013 · GM
Transduction of Schistosoma mansoni by pseudotyped retrovirus
$434,743Paul J Brindley · Tulane University Of Louisiana · R01 · FY2007 · AI
Novel RNA-Directed Therapy for the Treatment of Acute Myeloid Leukemia
$434,681Steven Terry Rosen · Beckman Research Institute/City Of Hope · R01 · FY2019 · CA
SCH: INT: Harnessing the Power of Technology: MOMBA for Postpartum Smoking
$434,652Megan Veenema Smith · Yale University · R01 · FY2014 · CA
Vector Integration and Tracking
$434,644Brian C Beard · Seattle Children'S Hospital · P01 · FY2013 · AI
The role, mechanism, and therapeutic potential of METTL1 in acute myeloid leukemia
$434,632Rui Su · Beckman Research Institute/City Of Hope · R37 · FY2025 · CA
Molecular Analysis of Normal and Thalassemic DNA
$434,631Stuart H Orkin · Boston Children'S Hospital · R01 · FY2015 · HL
Enhancing neutrophil function in neutropenia-related pneumonia
$434,631Hongbo R Luo · Boston Children'S Hospital · R01 · FY2015 · HL
Role of GAS41 in Human Cancer
$434,625Xiaobing Shi · Van Andel Research Institute · R01 · FY2020 · CA
The role of the SF3B1 splicing factor in chronic lymphocytic leukemia
$434,621Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2017 · HL
The role of the SF3B1 splicing factor in chronic lymphocytic leukemia
$434,621Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2016 · HL
REGULATION OF GENE EXPRESSION BY DNA BINDING LIGANDS
$434,589California Institute Of Technology · R01 · FY2000 · GM
Post-transplant vaccines to enhance graft-versus-leukemia responses
$434,583Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2010 · HL
Mechanisms of pox virus motility and release
$434,561Daniel Kalman · Emory University · R01 · FY2010 · AI
Genomics of Treatment -Related Acute Myelogenous Leukemia: Susceptibility Factors
$434,535Timothy A Graubert · Washington University · P01 · FY2008 · CA
Cellular Transduction with Replication-Competent Retrovirus Vectors
$434,515Noriyuki Kasahara · University Of California Los Angeles · R01 · FY2010 · CA
Optimization of gene transfer safety and efficacy focusing on the NHP model
$434,511Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Targeting microRNAs to eradicate leukemia stem cells
$434,503Ya-Huei Kuo · Beckman Research Institute/City Of Hope · R01 · FY2017 · CA
Control Mechanisms of Human Voltage Gated Proton Channels, hHv1
$434,500Thomas E Decoursey · Rush University Medical Center · R35 · FY2025 · GM
Control Mechanisms of Human Voltage Gated Proton Channels, hHv1
$434,500Thomas E Decoursey · Rush University Medical Center · R35 · FY2024 · GM
Natural product-derived differentiation agents for AML
$434,480Mukesh Kumar Agarwal · Invenio Therapeutics, Inc. · R44 · FY2011 · CA
Developmental Funds
$434,458Michelle M Le Beau · University Of Chicago · P30 · FY2020 · CA